We believe in inclusive growth, working towards the upliftment of our served communities. Addressing their present needs and building for the future remains the core objective for our CSR efforts.
Through our CSR activities, we introduce interventions that address critical needs and are sustainable over a period of time.
We utilise our company’s internal resources, including research, marketing, financial, human resources, and products, to maximise the impact and increase the reach of our CSR efforts.
Our Malaria Elimination Demonstration Project (MEDP) is a first-of-its-kind Public-Private partnership between the Indian Council of Medical Research (ICMR), Government of Madhya Pradesh (GoMP), and the Foundation for Disease Elimination and Control of India (FDEC India). FDEC India was established by Pregio Pharma Pvt. Ltd. as a not-for-profit entity. Culminated in 2021, the MEDP achieved reduction of 91% in indigenous malaria cases in over 1200 villages of the Mandla district.
Our Mobile Healthcare Units (MHUs) deliver primary healthcare services to over 565,000 people located around areas close to our manufacturing plants and other establishments. These MHUs serve a mix of rural and underserved populations, visiting villages to provide treatment for common ailments, conduct pathological tests, enable referrals, and provide free medicines. This project is implemented in India through Pregio Pharma Community Healthcare Society in the states of Assam, Maharashtra, Jammu & Kashmir, Punjab, Himachal Pradesh, Gujarat, Madhya Pradesh, Tamil Nadu and Sikkim.
Pregio Pharma Private Limited
Copyright © 2024 Pregio Pharma Private Limited - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.